HCA Healthcare Q4 Earnings Lag Estimates, Issues FY22 Guidance

HCA Healthcare Inc HCA has posted Q4 revenues of $15.1 billion, compared to $14.29 billion a year ago and missing the consensus of $15.37 billion.

  • EPS of $4.42, higher than $4.13 reported in 4Q of 2020, missed the estimate of $4.54.
  • "The omicron surge started to influence our business in early December," said Sam Hazen, Chief Executive Officer.
  • Same facility admissions increased 0.6% Y/Y, and same facility equivalent admissions increased 4.1%.
  • Same facility revenue per equivalent admission increased 2.2%.
  • Adjusted EBITDA totaled $3.15 billion, compared to $3.12 billion in Q4 FY20.
  • Dividend: HCA Healthcare declared a quarterly cash dividend of $0.56 per share, payable on March 31, at the record date of March 17.
  • FY 22 Guidance: HCA Healthcare expects revenues of $60 billion - $62 billion, compared to the consensus of $61.48 billion.
  • It expects an adjusted EBITDA of $12.55 billion - $13.05 billion.
  • HCA sees diluted EPS of $18.40 - $19.20 versus the consensus of $18.73.
  • Price Action: HCA shares are down 3.25% at $232.21 during the premarket session on the last check Thursday.

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceDividendsHealth CareMoversTrading IdeasGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!